Anti-CD120a/TNFRSF1A Polyclonal Antibody from ProteoGenix; catalogue ARO-A22120; research use only.
Know who made it. See the evidence. Buy through one marketplace.
Anti-CD120a/TNFRSF1A Polyclonal Antibody: A Powerful Tool for Targeting Inflammation and Autoimmune Diseases
The Anti-CD120a/TNFRSF1A Polyclonal Antibody is a highly specific and effective tool for studying inflammation and autoimmune diseases. This versatile antibody targets the CD120a/TNFRSF1A receptor, a key player in the inflammatory response, and has been extensively validated for use in a variety of experimental applications.
CD120a/TNFRSF1A is a cell surface receptor that belongs to the tumor necrosis factor (TNF) receptor superfamily. It is primarily expressed on immune cells and plays a crucial role in the regulation of inflammation and immune response. Upon binding to its ligand, TNF-alpha, CD120a/TNFRSF1A triggers a cascade of signaling events that lead to the activation of various inflammatory pathways. This makes it a promising target for the treatment of inflammatory and autoimmune diseases.
The Anti-CD120a/TNFRSF1A Polyclonal Antibody is a valuable tool for researchers studying inflammation and autoimmune diseases. It can be used in a wide range of applications, including Western blotting, immunohistochemistry, flow cytometry, and immunoprecipitation. This antibody has been shown to specifically recognize CD120a/TNFRSF1A in a variety of cell types and species, making it a reliable choice for diverse research needs.
The Anti-CD120a/TNFRSF1A Polyclonal Antibody has been successfully used in numerous studies to investigate the role of CD120a/TNFRSF1A in various inflammatory and autoimmune conditions. For example, it has been used to study the involvement of CD120a/TNFRSF1A in rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease. In addition, this antibody has been used to assess the efficacy of potential therapeutic agents targeting CD120a/TNFRSF1A.
Conclusion:
In summary, the Anti-CD120a/TNFRSF1A Polyclonal Antibody is a highly specific and reliable tool for studying inflammation and autoimmune diseases. Its ability to target the CD120a/TNFRSF1A receptor and its versatility in a variety of experimental applications make it an essential component of any research focused on these areas. With its proven effectiveness and extensive validation, this antibody is a valuable addition to any laboratory investigating the complex mechanisms of inflammation and autoimmunity.
Keywords: Anti-CD120a/TNFRSF1A Polyclonal Antibody, inflammation, autoimmune diseases, CD120a/TNFRSF1A receptor, TNF-alpha, Western blotting, immunohistochemistry, flow cytometry, immunoprecipitation, rheumatoid arthritis, multiple sclerosis, inflammatory bowel disease, therapeutic agents, research.
ProteoGenix catalogue number ARO-A22120. For research use only.
Target: Tumor necrosis factor receptor superfamily member 1A; Tumor necrosis factor receptor 1; TNF-R1; Tumor necrosis factor receptor type I; TNF-RI; TNFR-I; p55; p60; CD120a; Tnfrsf1a; Tnfr-1; Tnfr1; Clonality: Polyclonal Antibody; Applications: ELISA, IHC.
Available configurations: 50ug, 100ug, 1mg.
Fully tested in-house by ABMIUM, or supported by an advanced validation report from a partner reviewed by ABMIUM. Highest confidence. Non-conformities fully supported under the ABMIUM Product Promise.
Quality verified. Independent collaborator or expected-performance data available. Product meets ABMIUM quality standards.
Expected to work based on structural and biochemical data. Not yet directly tested by ABMIUM or a collaborator. No non-conformity support for this combination.
Not recommended for this application or species/sample combination. This may indicate either evidence of unsuitability or that the combination has not been tested and therefore cannot currently be recommended.
Evidence status by application and model.
| Target | WB | IHC-P | IHC-Fr | IF/ICC | Flow Cyt | IP | ChIP | ELISA | IHC |
|---|---|---|---|---|---|---|---|---|---|
| Tumor necrosis factor receptor superfamily member 1A; Tumor necrosis factor receptor 1; TNF-R1; Tumor necrosis factor receptor type I; TNF-RI; TNFR-I; p55; p60; CD120a; Tnfrsf1a; Tnfr-1; Tnfr1 |
This product is manufactured by ProteoGenix and sold through ABMIUM without relabelling.
ABMIUM supports global orders. Availability, shipping requirements and applicable import arrangements are confirmed before fulfilment where required.
Yes. Send your target, sample, application and experimental conditions through ABMIUM MATCH or technical support.
Unless the listing expressly states otherwise, ABMIUM products are supplied for research use only and are not for diagnostic or therapeutic use.
